🔗 Share this article

A shadow market for unapproved weight-loss medications is being driven by social media fitness personalities and vendors on messaging platforms, based on recent findings.

Experimental Treatment Gaining Popularity Online

Retatrutide, which is still in clinical trials, is being advertised by online personalities for its supposed weight-reducing effects. Followers are encouraged to message these profiles directly for supplier links, while also receiving discount codes.

Active Commerce on Social Networks

Separately, a robust trade exists on messaging services, where groups with thousands of participants share comparison photos, administration instructions and assertions of next-day British shipping. Sellers market the drug there before redirecting buyers to other platforms for purchases.

Learning About The Experimental Drug

This medication is an investigational injectable developed by US drugmaker Eli Lilly. The drug affects three gut hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies suggest it could assist patients reduce up to a quarter of their total weight. Referred to as the “triple G”, the drug is being promoted digitally as the successor to Ozempic.

Healthcare Professionals Express Worries

However, physicians and chemists have cautions that the distribution of what is still an unlicensed drug in the United Kingdom is a cause for concern and could lead to individuals administering products of unknown origin.

Some experts said the popularity for the experimental drug could be linked to the rising cost of approved slimming treatments such as Mounjaro.

Legal Position and Enforcement

Selling retatrutide on TikTok or Telegram is prohibited in the United Kingdom, as it is an unlicensed medication that cannot be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Some influencers try to circumvent the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and supply can still violate medicines, marketing, and customer laws, potentially leading to fines, legal action or prison.

Platform Reaction and Content Elimination

Based on TikTok, the service has taken down violative content and prohibited related keywords and query recommendations. The company said it was dedicated to keeping the platform secure and allocating resources in enhancing enforcement strategies.

Online Trading Operations

Research also found groups with up to nine thousand members marketing retatrutide using Telegram's integrated search feature, which operates like a public directory. Typing “retatrutide” immediately displays channels with thousands of users, populated with images of weight loss, glowing reviews and detailed instructions for mixing or administering at home.

After minutes of joining one community, a seller posted WhatsApp details, where the majority of purchases occur. The vendor provided an guidebook and promised delivery within two days. When asked whether the product was genuine, one seller responded: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. Not one inquired about weight, medical conditions or past usage.

Item Information and Pricing

Inside these communities, posts display black plastic packages with Royal Mail labels, claiming to include fresh supplies. One message read: “It took eight of us to load them this morning.”

Customers can choose between powder vials, prepared at home with sterile water, or pre-filled injectors typically priced at £160 for 20 milligrams. When questioned how long a injector should be used, vendors give contradictory responses ranging from a few weeks to “depends on your body”.

Platform Moderation and Safety Measures

A spokesperson for the messaging service said it regularly monitored harmful content on its platform including material that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“Individuals are administering materials they cannot confirm. Although the research behind this drug is sound, these digital products may not include what they claim,” said a pharmacy expert, the director of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor linked the increase in interest to recent price rises for approved weight-loss medications such as Mounjaro. “With prices rising, patients are turning to online platforms. But fake injections are extremely risky. You cannot know what’s contained or whether the environment they were made in was sterile,” she said.

Her team has already encountered patients injured by self-injection from unconfirmed sources. “We understand the frustration, but purchasing from Telegram or communication platforms is taking chances with your health,” stated Wyllie. “These substances could be impure or improperly measured.”

Producer Position

A spokesperson from Eli Lilly said the substance was in phase 3 clinical trials and had not been reviewed or authorized by any regulatory agency globally. “Therefore at this time no one can sell [it] for personal consumption,” they explained, adding that any product “falsely representing itself as a Lilly investigational substance not yet approved … may expose patients to potentially serious medical dangers”.